Carcinoembryonic antigen (CEA), a non-specific serum biomarker, functions as a prognostic biomarker and can be used in monitoring the treatment of many malignancies, such as gastric, pancreatic, and colorectal cancers. The gene discussed is CEACAM5; the disease is colorectal cancer.